Showing results (71-80 of 101) with videos related to

Sort By:
Pageof 11
Neurology|September 1, 1993
Double-blind, placebo-controlled, crossover study of duodenal infusion of levodopa/carbidopa in Parkinson's disease patients with 'on-off' fluctuationsM C Kurth, J W Tetrud, C M Tanner, et al.
Neurology|July 1, 1988
Controlled-release carbidopa/levodopa (CR4-Sinemet) in Parkinson's disease patients with and without motor fluctuationsC G Goetz, C M Tanner, K M Shannon, et al.
Spine|June 1, 2000
The rates of false-positive lumbar discography in select patients without low back symptomsE J Carragee, C M Tanner, S Khurana, et al.
Neuroscience Letters|November 22, 1988
An antibody in the CSF of Parkinson's disease patients disappears following adrenal medulla transplantationA McRae-Degueurce, H L Klawans, R D Penn, et al.
Neurology|July 1, 1996
CYP2D6 allelic frequencies in young-onset Parkinson's diseaseM S Sandy, M Armstrong, C M Tanner, et al.
Diabetologia|August 13, 2010
Day/night variations of high-molecular-weight adiponectin and lipocalin-2 in healthy men studied under fed and fasted conditionsF A J L Scheer, J L Chan, J Fargnoli, et al.
Neurosurgery|June 1, 1988
The adrenal medullary transplant operation for Parkinson's disease: clinical observations in five patientsR D Penn, C G Goetz, C M Tanner, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 22, 2001
An impairment in sniffing contributes to the olfactory impairment in Parkinson's diseaseN Sobel, M E Thomason, I Stappen, et al.
Neurology|November 9, 2005
Excessive daytime sleepiness and subsequent development of Parkinson diseaseR D Abbott, G W Ross, L R White, et al.
Neurology|August 10, 2005
Effect of reproductive factors and postmenopausal hormone use on the risk of Parkinson diseaseR A Popat, S K Van Den Eeden, C M Tanner, et al.
Pageof 11